Novartis collaborates with Incyte with initiation plan of clinical study of Jakavi in COVID-19 patients Medical Dialogues Bureau6 April 2020 9:54 AM GMTBasel: Novartis has announced plans to initiate a Phase III clinical trial in collaboration with Incyte to evaluate the use of Jakavi® (ruxolitinib) fo...
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for Alopecia Areata Medical Dialogues Bureau19 March 2020 7:26 AM GMTBaricitinib is currently approved for the treatment of adults with moderately to severely active rheumatoid arthritis (RA).
